Trial Profile
Hysterectomy and Levonorgestrel-releasing IUS in the Treatment of Menorrhagia
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 05 Mar 2020
Price :
$35
*
At a glance
- Drugs Levonorgestrel (Primary)
- Indications Menorrhagia
- Focus Biomarker; Therapeutic Use
- Acronyms VUOKKO
- 12 Jun 2011 Ten-year follow-up results assessing the effect of treatment on serum inflammatory marker levels presented at the 13th World Congress on Menopause.
- 15 Feb 2010 Results published in BJOG: An International Journal of Obstetrics and Gynaecology.
- 26 Dec 2009 Results were published in Acta Obstetricia et Gynecologica Scandinavica.